Azora Therapeutics, Inc. (AZR)

Healthcare · Medical - Pharmaceuticals · NASDAQ · US

$4.88-3.37%Close

The free White Arrow call is the 25-name SPY25 preview. Essential unlocks AZR.

COMPARE

AZR

$4.88-3.37%

Overview Financials Earnings Analyst & RatingsAnalyst News Holders & ETFsHolders Options

RANGE

LOPJLB.COM

OHLCOHLC, Essential layerEMAEMALEVELS, Essential layerSTOPStop, Essential layerFLIPFlip, Essential layer52W52-weekSIGNALS, Essential layerBUYBuy, Essential layerSELLSell, Essential layerEXHExhaustion, Essential layerEXH ZONEExhaustion zone, Essential layerCOILCoil

Oct 29, 2026O 4.50H 4.97L 3.67C 4.88-3.37%V 146.9K

Snapshot

Price & returns

1 week: +15.6%+14.9% vs SPY
1 month: +17.6%+16.9% vs SPY

Valuation

Market cap: $12.8M

Signal: Call, Regime, Alignment, Score, ATR trend, HiLo flip, Coil, Exhaustion, Topping · Technicals (EMA stack, slope, squeeze, stochastic, MACD-Z, DI+) · Price & returns: 3 months, Year to date, 1 year

Price & returns: 3 years, 5 years

Signal: Composite · Performance (Q-Score, Sharpe, Sortino, Calmar, CAGR, drawdown, alpha)

Signal evidence

How it works

Best Combo (today's action, held-out profit factor and family votes) · White Arrow (the call, its profit factor and closed trades) · Regime (today's regime and the regime model's profit factor) · Exhaustion (whether buyers or sellers are stretched today and the latest release)

Lists

Quality dividend stocks

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

About

Azora Therapeutics, Inc. (AZR). Azora Therapeutics is a biopharmaceutical company developing treatments for serious inflammatory diseases. Its lead program, AT177, is an oral, colon-targeted aryl hydrocarbon receptor agonist in development for ulcerative colitis.

Profile

SectorHealthcare

IndustryMedical - Pharmaceuticals

ExchangeNASDAQ

CountryUS

CEOCary J. Claiborne

IPOJul 27, 2018

Employees6

Shares outstanding2.6M

Float2.4M

Free float-

Websiteazoratherapeutics.com ↗